Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15198957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system.

  2004cited by this paper
• Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease.

  2003cited by this paper
• Gene length and proximity to neighbors affect genome-wide expression levels.

  2003cited by this paper
• The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.

  2003cited by this paper
• Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.

  2003cited by this paper
• Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells.

  2003cited by this paper
• Side effects of retroviral gene transfer into hematopoietic stem cells.

  2003cited by this paper
• Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

  2003cited by this paper
• A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.

  2003cited by this paper
• Update on gene therapy for hemoglobin disorders.

  2003cited by this paper
• Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.

  2003cited by this paper
• Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system.

  2003cited by this paper
• Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells.

  2003cited by this paper
• Transcriptional Interference by Independently Regulated Genes Occurs in Any Relative Arrangement of the Genes and Is Influenced by Chromosomal Integration Position

  2002cited by this paper
• HIV-1 integration in the human genome favors active genes and local hotspots.

  2002cited by this paper
• Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood.

  2002cited by this paper
• Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells

  2002cited by this paper
• Update on hematopoietic stem cell gene transfer using non-human primate models.

  2002cited by this paper
• High-Level Erythroid Lineage-Directed Gene Expression Using Globin Gene Regulatory Elements After Lentiviral Vector-Mediated Gene Transfer into Primitive Human and Murine Hematopoietic Cells

  2002cited by this paper
• Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.

  2001cited by this paper
• Sequences Flanking Hypersensitive Sites of the β-Globin Locus Control Region Are Required for Synergistic Enhancement

  2001cited by this paper
• High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors.

  2001cited by this paper
• Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy

  2001cited by this paper
• Beta-globin YAC transgenes exhibit uniform expression levels but position effect variegation in mice.

  2000cited by this paper
• Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.

  2000cited by this paper
• Patterns of variant polyadenylation signal usage in human genes.

  2000cited by this paper
• Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter.

  2000cited by this paper
• Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.

  1999cited by this paper
• Analysis of gamma-Globin Expression Cassettes in Retrovirus Vectors

  1999cited by this paper
• Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.

  1999cited by this paper
• Induction of fetal hemoglobin in sickle cell disease.

  1999cited by this paper
• The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice.

  1997cited by this paper
• Locus control regions of mammalian beta-globin gene clusters: combining phylogenetic analyses and experimental results to gain functional insights.

  1997cited by this paper
• Role of DNA sequences outside the cores of DNase hypersensitive sites (HSs) in functions of the beta-globin locus control region. Domain opening and synergism between HS2 and HS3.

  1996cited by this paper
• Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription.

  1996cited by this paper
• Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line.

  1993cited by this paper
• Insertion mutagenesis of embryonal carcinoma cells by retroviruses.

  1985cited by this paper

• The development of an advanced lentiviral gene therapy for beta-thalassemia.

  2025cites this paper
• Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies

  2023cites this paper
• Globin vector regulatory elements are active in early hematopoietic progenitor cells

  2022cites this paper
• Gene therapy and editing in the treatment of hereditary blood disorders: Medical and ethical aspects

  2021cites this paper
• Inference for High-Dimensional Censored Quantile Regression

  2021cites this paper
• Design of non-viral vector with improved regulatory features towards therapeutic application

  2020cites this paper
• Innovative Therapies for Hemoglobin Disorders

  2020cites this paper
• The mRNA-Binding Protein IGF2BP1 Restores Fetal Hemoglobin in Cultured Erythroid Cells from Patients with β-Hemoglobin Disorders

  2020cites this paper
• Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's disease.

  2020cites this paper
• Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders

  2019cites this paper
• A Systematic Bioinformatics Approach to Motif-Based Analysis of Human Locus Control Regions

  2019cites this paper
• Gene therapy and gene editing strategies for hemoglobinopathies.

  2018cites this paper
• Genetic Therapies for Sickle Cell Disease.

  2018cites this paper
• Gene Therapy for Hemoglobinopathies

  2018cites this paper
• Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.

  2018cites this paper
• Promise of gene therapy to treat sickle cell disease

  2018cites this paper
• Treatment of β654‐thalassaemia by TALENs in a mouse model

  2018cites this paper
• Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia.

  2017cites this paper
• Gene Therapy Approaches to Hemoglobinopathies.

  2017cites this paper
• Gene Therapy for β-Hemoglobinopathies.

  2017cites this paper
• Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.

  2017cites this paper
• Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells.

  2017cites this paper
• Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene

  2016cites this paper
• Current and future alternative therapies for beta-thalassemia major

  2016cites this paper
• Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers.

  2016cites this paper
• The Sea Urchin sns5 Chromatin Insulator Shapes the Chromatin Architecture of a Lentivirus Vector Integrated in the Mammalian Genome

  2016cites this paper
• Globin gene regulation for treating β-thalassemias: progress, obstacles and future

  2015influential citation
• Retrovirus-based vectors for transient and permanent cell modification.

  2015cites this paper
• Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.

  2015cites this paper
• Recent trends in the gene therapy of β-thalassemia

  2015cites this paper
• The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cells

  2015cites this paper
• Quantitative Shearing Linear Amplification Polymerase Chain Reaction: An Improved Method for Quantifying Lentiviral Vector Insertion Sites in Transplanted Hematopoietic Cell Systems

  2014cites this paper
• Image Guidance in Stem Cell Therapeutics: Unfolding the Blindfold.

  2014cites this paper
• Recent trends for novel options in experimental biological therapy of β-thalassemia

  2014cites this paper
• β-globin gene transfer to human bone marrow for sickle cell disease.

  2013cites this paper
• Gene therapy for hemoglobinopathies: progress and challenges.

  2013cites this paper
• Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia

  2013cites this paper
• Lentivirus vectors in β-thalassemia.

  2012cites this paper
• Alternative options for DNA-based experimental therapy of β-thalassemia

  2012cites this paper
• High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vector.

  2012cites this paper
• Development of gene therapy for thalassemia.

  2012cites this paper
• The New Self-Inactivating Lentiviral Vector for Thalassemia Gene Therapy Combining Two HPFH Activating Elements Corrects Human Thalassemic Hematopoietic Stem Cells

  2012cites this paper
• Μελέτη της δράσης φορέων τύπου spuma που εκφράζουν anti-α σφαιρίνης shRNA (short hairpin RNA) και β-σφαιρίνη σε πειραματικά μοντέλα θαλασσαιμίας

  2011cites this paper
• The Ongoing Challenge of Hematopoietic Stem Cell-Based Gene Therapy for β-Thalassemia

  2011cites this paper
• The GATA1-HS2 Enhancer Allows Persistent and Position-Independent Expression of a β-globin Transgene

  2011cites this paper
• Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.

  2011cites this paper
• Recent advances in β-thalassemias

  2011cites this paper
• Two distinct syndromes of lymphoma associated AL amyloidosis: A case series and review of the literature

  2010cites this paper
• Major challenges for gene therapy of thalassemia and sickle cell disease.

  2010cites this paper
• The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in β‐thalassemia patients

  2010cites this paper
• Association with TP53 codon 72 polymorphism and the risk of non‐Hodgkin lymphoma

  2010cites this paper
• Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.

  2010cites this paper
• Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

  2010cites this paper
• Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?

  2010cites this paper
• Successful treatment of severe extremity pain in myelofibrosis with low‐dose single‐fraction radiation therapy

  2010cites this paper
• TRANSFECTION OF HUMAN HEMATOPOIETIC STEM CELLS BY A GENE TARGETING CONSTRUCT CONTAINING THE β-GLOBIN GENE

  2010cites this paper
• Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort

  2010cites this paper
• MALT lymphoma and Kaposi Sarcoma in an HIV‐negative patient

  2010cites this paper
• Prolonged Survival and Phenotypic Correction of Akp2−/− Hypophosphatasia Mice by Lentiviral Gene Therapy

  2010cites this paper
• A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

  2010cites this paper
• Successful correction of murine sickle cell disease with reduced stem cell requirements reinforced by fractionated marrow infusions

  2010cites this paper
• Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective

  2010cites this paper
• Genetic therapy for beta-thalassemia: from the bench to the bedside.

  2010cites this paper
• Hemolytic anemia and distal renal tubular acidosis in two Indian patients homozygous for SLC4A1/AE1 mutation A858D

  2010cites this paper
• Therapy for β‐globinopathies: a brief review and determinants for successful and safe correction

  2010cites this paper
• Iron overload cardiomyopathy: better understanding of an increasing disorder.

  2010cites this paper
• Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.

  2010cites this paper
• Recent advances in lentiviral vector development and applications.

  2010cites this paper
• Follow‐up report on the 2‐year cardiac data from a deferasirox monotherapy trial

  2010cites this paper
• Analysis of alpha hemoglobin stabilizing protein overexpression in murine β‐thalassemia

  2010cites this paper
• High early mortality rate in elderly patients with multiple myeloma receiving a vincristine–doxorubicin–dexamethasone regimen

  2010cites this paper
• Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis

  2010cites this paper
• Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene.

  2009cites this paper
• Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression

  2009cites this paper
• In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene.

  2009cites this paper
• Murine Leukemia Virus as a Vector to Transfer Genes into Blood Stem Cells : Success in Two Immunodeficiency Disorders

  2009cites this paper
• Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.

  2009cites this paper
• Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element.

  2009cites this paper
• Optimized Lentiviral Vector Design Improves Titer and Transgene Expression of Vectors Containing the Chicken β-Globin Locus HS4 Insulator Element.

  2009cites this paper
• Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin.

  2009cites this paper
• Current status of globin gene therapy for the treatment of β‐thalassaemia

  2008cites this paper
• In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemia

  2008cites this paper
• Hematopoietic cell transplantation for hemoglobinopathies.

  2008cites this paper
• An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.

  2008cites this paper
• Development of gene therapy for blood disorders.

  2008cites this paper
• Mouse models of sickle cell disease.

  2008cites this paper
• Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.

  2008cites this paper
• Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.

  2008cites this paper
• Optimization of Recombinant Adeno-Associated Viral Vectors for Human β-Globin Gene Transfer and Transgene Expression

  2008cites this paper
• Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy.

  2007cites this paper
• Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element.

  2007cites this paper
• Report on the Workshop “New Technologies in Stem Cell Research,” Society for Pediatric Research, San Francisco, California, April 29, 2006

  2007cites this paper
• Molecular therapies in β‐thalassaemia

  2007cites this paper
• Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic mice.

  2007cites this paper
• Modification of globin gene expression by RNA targeting strategies.

  2007cites this paper
• Site-specific transfer of an intact beta-globin gene cluster through a new targeting vector.

  2007cites this paper
• A chromatin insulator blocks interactions between globin regulatory elements and cellular promoters in erythroid cells.

  2007cites this paper
• The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectors.

  2007cites this paper
• Title: Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in β-thalassemic mice Running title: New globin lentiviral vectors for β-thalassemia.

  2007cites this paper
• Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.

  2006cites this paper